Case Discussions II-Complications and Recurrences

Abhinav Sidana, MD, MPH, FACS,  is an Associate Professor of Surgery, the Director of the Prostate Cancer Focal Therapy Program, the Co-Director of the High-Risk and Advanced Prostate Cancer Clinic, and a Urologic Oncologist at the University of Chicago in Illinois. Dr. Sidana specializes in prostate and kidney cancer, performing both robotic and open surgery for patients diagnosed with urologic cancers. He offers robotic prostatectomy for patients with more aggressive prostate cancer, and performs open and robotic surgery for patients with complex, multifocal, and advanced kidney cancers. Dr. Sidana’s research focuses on providing organ-preserving treatment, with lower side effects, for prostate cancer. He has extensive experience with cryoablation, high-intensity focused ultrasound ablation, TULSA Pro, and irreversible electroporation of the prostate.

Arvin K. George, MD, serves as Director of Prostate Cancer Programs and Associate Professor (PAR) of Urology at Johns Hopkins School of Medicine in Baltimore, Maryland. He is a urologic surgeon who specializes in the diagnosis and management of genitourinary cancers. After obtaining his medical degree from the Royal College of Surgeons in Ireland, he completed his urology residency at the Smith Institute for Urology at the Hofstra North Shore-LIJ School of Medicine. He remained there to complete his endourology fellowship in New York, gaining additional subspecialty expertise in robotic, laparoscopic, and percutaneous surgery. Subsequently, he completed a urologic oncology fellowship at the National Cancer Institute of the National Institutes of Health. Dr. George’s research interests include minimally-invasive and image-guided treatments, functional prostate imaging, and focal therapy for prostate cancer. His research aims to identify appropriate use for imaging in diagnosis, risk stratification, and management of prostate cancer, including active surveillance and selection/treatment of patients with novel focal therapy modalities.

Taimur Shah, MBBS, BSc, FRCS, PhD, is a Clinical Associate Professor and Consultant Urologist at Imperial College London in England. Dr. Shah has a sub-specialist interest in prostate cancer diagnostics, imaging, robotic surgery, focal therapy for prostate cancer, and minimally invasive treatments for benign prostatic hyperplasia.

Thomas P. Frye, DO, is a Urologic Oncologist serving as Associate Professor of Urology and Vice Chair of Clinical Affairs for the Department of Urology at the University of Rochester Medical Center in Rochester, New York. Dr. Frye specializes in both minimally invasive urologic oncology (robotic surgery for prostate and kidney cancers), and advanced open pelvic and retroperitoneal cancer surgery. He has a special interest and expertise in the management of localized prostate cancer with focal therapy. 

Alice Yu, MD, MPH, is a Urologic Surgeon and Assistant Member in the Department of GU Oncology at the H. Lee Moffitt Cancer Center in Tampa, Florida, and also serves as an Assistant Professor in the Department of Oncologic Sciences at the University of South Florida in Tampa. Her clinical practice focuses on the surgical treatment of urologic cancers, including prostate, bladder, kidney, penile, and testicular cancer, using minimally invasive (laparoscopic and robotic) and open techniques. She is interested in surgical outcomes research and quality improvement with a focus on bladder and prostate cancers.